FDA 483 - Vitane Pharmaceutical, Inc. - October 23, 2024
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Vitane Pharmaceutical, Inc. in Congers, NY, was inspected regarding its drug product repackaging and relabeling operations. The inspection revealed significant deficiencies across multiple areas, including a lack of validated production and process controls, inadequate equipment cleaning validation, insufficient supplier qualification, improper drug product storage conditions, and a failure to conduct annual product reviews. These issues indicate a systemic lack of adherence to quality standards for drug products.
ID · 89ca698e-be71-48ec-a1eb-8807de58884a